Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Anna Gloyn, Professor of Molecular Genetic and Metabolism at OCDEM & the WCHG, is this year’s Diabetes UK Dorothy Hodgkin Award lecture winner.

Professor Gloyn (pictured) gave her lecture to a packed audience at the Diabetes UK Professional Conference on Thursday 7th March 2019. Her lecture, entitled ‘Type 2 Diabetes GWAS: from bench to bedside’ began with a tribute to Dorothy Hodgkin, and explored the genetic architecture of Type 2 Diabetes – including how insights from this basic lab-based research could be used to improve and personalise clinical treatments for patients.

AnnaGloynHeadingtonPrepSchoolsketch.PNGProfessor Gloyn illustrated her talk with pictures of scientists drawn by primary school children (see right) from girls at the Headington Prep school that she has engaged with her team’s work, and discussed her team’s interest in how specific genes affect the function of beta cells in the pancreas, such as how they produce, store and release insulin. Modelling these functions in a lab helps scientists understand what happens in a person with genetic variations which affect these functions.

The talk surveyed how multiple genetic variants affect the risk of Type 2 diabetes, and how genetic research is zooming in on the specific molecules involved to understand why.

Understanding these molecular mechanisms opens up opportunities for new treatments, but Professor Gloyn emphasised that team science is the key to success.  

The lecture was also commended for emphasising the role of women and girls in science.

Many congratulations to Professor Gloyn!

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with


Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.